Despite stringent restrictions on research, cannabinoid science has grown by leaps and bounds over the last three decades. In 2018, it culminated in the appro...
The much-anticipated ruling from the DEA left CBD, the active ingredient in the newly approved Epidiolex medication, on Schedule I. Now it turns out that even a...
The approval of Epidiolex, a marijuana-derived CBD drug from GW Pharmaceuticals, will have ramifications throughout the hemp and medical marijuana markets.
O...
We are on the verge of history, as the U.S. Food and Drug Administration (FDA) is expected to approve the first cannabis-derived pharmaceutical in the U.S. on J...
For the first time, an FDA advisory panel granted approval to a cannabis-derived medication — and experts predict that the FDA will fully approve the drug in th...
